Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with type 2 diabetes
The clinician selects the relevant markers based on your intake, then designs a bioidentical hormone protocol around where you actually are in the transition
November 19, 2019
While results can vary from person to person, most GLP-1 medications tend to start working within the first week of use
At first glance, a very low-calorie diet seems positive if you want to lose weight
not intended as a treatment recommendation) Courses Mentioned Courses Mentioned Timestamps Timestamps 00:00 Introduction and course overview 02:03 Early biomarker detection and childhood metabolic health 04:07 Evolution from Blood Labs 101 to 201 08:27 Understanding C-peptide and insulin activity 11:08 Fructosamine and short-term glucose trends 13:24 Adiponectin and leptin in inflammation and metabolism 15:20 Oxidative stress, LDH, glutathione, and DNA damage 17:20 GGT and antioxidant balance 20:54 Cytokines, NK cells, and the SIRI index 26:07 Monocytes and immune pattern recognition 32:41 Why each clinician chose medicine 50:52 Personal growth and lessons beyond the clinic 54:00 Final reflections Learn More Learn More Dr
.png)
